Effect of celecoxib on cyclooxygenase-1-mediated prostacyclin synthesis and endothelium-dependent contraction in mouse arteries

European Journal of Pharmacology

Volumn 698, Issue 1-3, 2013, Pages 354-361

  Liu, Bin ^a   Luo, Wenhong ^a   Zhang, Yingzhan ^a   Li, Hui ^a   Zhu, Ningxia ^a   Huang, Dongyang ^a   Zhou, Yingbi ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Contraction; COX 2; Inhibitor; Metabolite; PGI2; TP receptor

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CELECOXIB; CYCLOOXYGENASE 1; NITRIC OXIDE SYNTHASE; PROSTACYCLIN;

ABDOMINAL AORTA; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CARDIOVASCULAR EFFECT; CAROTID ARTERY; CONTROLLED STUDY; ENZYME INHIBITION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASOMOTOR REFLEX;

ACETYLCHOLINE; ANIMALS; AORTA, ABDOMINAL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; INDOMETHACIN; MALE; MICE; MICE, INBRED C57BL; PHENYLEPHRINE; PYRAZOLES; SULFONAMIDES; VASOCONSTRICTION;

EID: 84871928525     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.10.040     Document Type: Article

References (42)

1. H.R. Ansari, A. Nadeem, S.L. Tilley, and S.J. Mustafa Involvement of COX-1 in A3 adenosine receptor-mediated contraction through endothelium in mice aorta Am. J. Physiol. Heart Circ. Physiol. 293 2007 H3448 3455
2. C. Bolego, C. Buccellati, A. Prada, R.M. Gaion, G. Folco, and A. Sala Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone FASEB J. 23 2009 605 612
3. L.I. Brueggemann, A.R. Mackie, B.K. Mani, L.L. Cribbs, and K.L. Byron Differential effects of selective cyclooxygenase-2 inhibitors on vascular smooth muscle ion channels may account for differences in cardiovascular risk profiles Mol. Pharmacol. 76 2009 1053 1061
4. S. Bunting, R. Gryglewski, S. Moncada, and J.R. Vane Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation Prostaglandins 12 1976 897 913 (Pubitemid 8015243)
5. R. Chenevard, D. Hurlimann, M. Bechir, F. Enseleit, L. Spieker, M. Hermann, W. Riesen, S. Gay, R.E. Gay, M. Neidhart, B. Michel, T.F. Luscher, G. Noll, and F. Ruschitzka Selective COX-2 inhibition improves endothelial function in coronary artery disease Circulation 107 2003 405 409
6. D.N. Derkach, E. Ihara, K. Hirano, J. Nishimura, S. Takahashi, and H. Kanaide Thrombin causes endothelium-dependent biphasic regulation of vascular tone in the porcine renal interlobar artery Br. J. Pharmacol. 131 2000 1635 1642 (Pubitemid 32056429)
7. M. Feletou, T.J. Verbeuren, and P.M. Vanhoutte Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors Br. J. Pharmacol. 156 2009 563 574
8. G.A. FitzGerald, and C. Patrono The coxibs, selective inhibitors of cyclooxygenase-2 N. Engl. J. Med. 345 2001 433 442 (Pubitemid 32747607)
9. P. Gluais, M. Lonchampt, J.D. Morrow, P.M. Vanhoutte, and M. Feletou Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin Br. J. Pharmacol. 146 2005 834 845 (Pubitemid 41622250)
10. T. Grosser, S. Fries, and G.A. FitzGerald Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities J. Clin. Invest. 116 2006 4 15 (Pubitemid 43121782)
11. Z. Guo, W. Su, S. Allen, H. Pang, A. Daugherty, E. Smart, and M.C. Gong COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice Cardiovasc. Res. 67 2005 723 735 (Pubitemid 41033368)
12. M. Hermann, G. Camici, A. Fratton, D. Hurlimann, F.C. Tanner, J.P. Hellermann, M. Fiedler, J. Thiery, M. Neidhart, R.E. Gay, S. Gay, T.F. Luscher, and F. Ruschitzka Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension Circulation 108 2003 2308 2311 (Pubitemid 37413534)
13. B. Hinz, B. Renner, and K. Brune Drug insight: cyclo-oxygenase-2 inhibitors - a critical appraisal Nat. Clin. Pract. Rheumatol. 3 2007 552 560 (Pubitemid 47506013)
14. E. Ihara, D.N. Derkach, K. Hirano, J. Nishimura, H. Nawata, and H. Kanaide Ca(2+) influx in the endothelial cells is required for the bradykinin-induced endothelium-dependent contraction in the porcine interlobar renal artery J. Physiol. 534 2001 701 711 (Pubitemid 32700868)
15. E. Ihara, K. Hirano, D.N. Derkach, J. Nishimura, H. Nawata, and H. Kanaide The mechanism of bradykinin-induced endothelium-dependent contraction and relaxation in the porcine interlobar renal artery Br. J. Pharmacol. 129 2000 943 952 (Pubitemid 30142907)
16. T. Klein, M. Eltze, T. Grebe, A. Hatzelmann, and M. Komhoff Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition Cardiovasc. Res. 75 2007 390 397 (Pubitemid 46961916)
17. B. Liu, W. Luo, Y. Zhang, H. Li, J. Zhang, X.R. Tan, and Y. Zhou Concomitant activation of functionally opposing prostacyclin and thromboxane-prostanoid receptors by cyclooxygenase-1-mediated prostacyclin synthesis in mouse arteries Exp. Physiol. 97 2012 895 904
18. B. Liu, W. Luo, Y. Zhang, H. Li, N. Zhu, D. Huang, and Y. Zhou Involvement of cyclooxygenase-1-mediated prostacyclin synthesis in the vasoconstrictor activity evoked by ACh in mouse arteries Exp. Physiol. 97 2012 277 289
19. B. Liu, W. Luo, Y. Zhang, H. Li, N. Zhu, D. Huang, and Y. Zhou Role of cyclooxygenase-1-mediated prostacyclin synthesis in endothelium-dependent vasoconstrictor activity of porcine interlobular renal arteries Am. J. Physiol. Renal Physiol. 302 2012 F1133 F1140
20. S.G. Morham, R. Langenbach, C.D. Loftin, H.F. Tiano, N. Vouloumanos, J.C. Jennette, J.F. Mahler, K.D. Kluckman, A. Ledford, C.A. Lee, and O. Smithies Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse Cell 83 1995 473 482
21. A.L. Mundy, E. Haas, I. Bhattacharya, C.C. Widmer, M. Kretz, R. Hofmann-Lehmann, R. Minotti, and M. Barton Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity Cardiovasc. Res. 73 2007 368 375 (Pubitemid 44937703)
22. K. Niwa, C. Haensel, M.E. Ross, and C. Iadecola Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation Circ. Res. 88 2001 600 608 (Pubitemid 32275796)
23. T. Ochi, Y. Motoyama, and T. Goto The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models Eur. J. Pharmacol. 391 2000 49 54 (Pubitemid 30138079)
24. E.B. Okon, A. Golbabaie, and C. van Breemen In the presence of L-NAME SERCA blockade induces endothelium-dependent contraction of mouse aorta through activation of smooth muscle prostaglandin H2/thromboxane A2 receptors Br. J. Pharmacol. 137 2002 545 553 (Pubitemid 35221909)
25. S.K. Paulson, T.A. Kaprak, C.J. Gresk, D.M. Fast, M.T. Baratta, E.G. Burton, A.P. Breau, and A. Karim Plasma protein binding of celecoxib in mice, rat, rabbit, dog and human Biopharm. Drug Dispos. 20 1999 293 299 (Pubitemid 30071751)
26. S.K. Paulson, M.B. Vaughn, S.M. Jessen, Y. Lawal, C.J. Gresk, B. Yan, T.J. Maziasz, C.S. Cook, and A. Karim Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption J. Pharmacol. Exp. Ther. 297 2001 638 645 (Pubitemid 32377995)
27. T.D. Penning, J.J. Talley, S.R. Bertenshaw, J.S. Carter, P.W. Collins, S. Docter, M.J. Graneto, L.F. Lee, J.W. Malecha, J.M. Miyashiro, R.S. Rogers, D.J. Rogier, S.S. Yu, Gd Anderson, E.G. Burton, J.N. Cogburn, S.A. Gregory, C.M. Koboldt, W.E. Perkins, K. Seibert, A.W. Veenhuizen, Y.Y. Zhang, and P.C. Isakson Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib) J. Med. Chem. 40 1997 1347 1365 (Pubitemid 27198082)
28. J. Quilley, and Y.J. Chen Role of COX-2 in the enhanced vasoconstrictor effect of arachidonic acid in the diabetic rat kidney Hypertension 42 2003 837 843 (Pubitemid 37237333)
29. S.P. Range, L. Pang, E. Holland, and A.J. Knox Selectivity of cyclo-oxygenase inhibitors in human pulmonary epithelial and smooth muscle cells Eur. Respir. J. 15 2000 751 756 (Pubitemid 30196305)
30. D. Riendeau, M.D. Percival, S. Boyce, C. Brideau, S. Charleson, W. Cromlish, D. Ethier, J. Evans, J.P. Falgueyret, A.W. Ford-Hutchinson, R. Gordon, G. Greig, M. Gresser, J. Guay, S. Kargman, S. Leger, J.A. Mancini, G. O'Neill, M. Ouellet, I.W. Rodger, M. Therien, Z. Wang, J.K. Webb, E. Wong, and C.C. Chan Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor Br. J. Pharmacol. 121 1997 105 117 (Pubitemid 27195011)
31. M.A. Soloviev, N.V. Kulakova, T.A. Semiglazova, E.V. Borodulina, and V.V. Udut Correction of endothelial dysfunction in patients with arterial hypertension Bull. Exp. Biol. Med. 151 2011 183 185
32. D. Stempak, J. Gammon, J. Klein, G. Koren, and S. Baruchel Single-dose and steady-state pharmacokinetics of celecoxib in children Clin. Pharmacol. Ther. 72 2002 490 497 (Pubitemid 36237719)
33. D. Sun, H. Liu, C. Yan, A. Jacobson, C. Ojaimi, A. Huang, and G. Kaley COX-2 contributes to the maintenance of flow-induced dilation in arterioles of eNOS-knockout mice Am. J. Physiol. Heart Circ. Physiol. 291 2006 H1429 1435
34. -/- knockout mice J. Cardiovasc. Pharmacol. 46 2005 761 765 (Pubitemid 44378247)
35. T. Traupe, M. Lang, W. Goettsch, K. Munter, H. Morawietz, W. Vetter, and M. Barton Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression J. Hypertens. 20 2002 2239 2245 (Pubitemid 35388243)
36. P.M. Vanhoutte Endothelium-dependent contractions in hypertension: when prostacyclin becomes ugly Hypertension 57 2011 526 531
37. M.E. Widlansky, D.T. Price, N. Gokce, R.T. Eberhardt, S.J. Duffy, M. Holbrook, C. Maxwell, J. Palmisano, J.F. Keaney Jr., J.D. Morrow, and J.A. Vita Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension Hypertension 42 2003 310 315 (Pubitemid 37093478)
38. S.L. Wong, F.P. Leung, C.W. Lau, C.L. Au, L.M. Yung, X. Yao, Z.Y. Chen, P.M. Vanhoutte, M. Gollasch, and Y. Huang Cyclooxygenase-2-derived prostaglandin F2alpha mediates endothelium-dependent contractions in the aortae of hamsters with increased impact during aging Circ. Res. 104 2009 228 235
39. F.E. Xavier, R. Aras-Lopez, I. Arroyo-Villa, L.D. Campo, M. Salaices, L.V. Rossoni, M. Ferrer, and G. Balfagon Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin Br. J. Pharmacol. 154 2008 1225 1235 (Pubitemid 351992068)
40. M. Zhao, X. He, M. Zhao, X.Y. Bi, H.L. Zhang, X.J. Yu, J.J. Liu, D.L. Li, X. Ma, and W.J. Zang Low-dose celecoxib improves coronary function after acute myocardial ischaemia in rabbits Clin. Exp. Pharmacol. Physiol. 39 2012 233 240
41. Y. Zhou, S. Mitra, S. Varadharaj, N. Parinandi, J.L. Zweier, and N.A. Flavahan Increased expression of cyclooxygenase-2 mediates enhanced contraction to endothelin ETA receptor stimulation in endothelial nitric oxide synthase knockout mice Circ. Res. 98 2006 1439 1445 (Pubitemid 43948069)
42. Y. Zhou, S. Varadharaj, X. Zhao, N. Parinandi, N.A. Flavahan, and J.L. Zweier Acetylcholine causes endothelium-dependent contraction of mouse arteries Am. J. Physiol. Heart Circ. Physiol. 289 2005 H1027 1032